9.94
Aligos Therapeutics Inc (ALGS) 最新ニュース
Aligos Therapeutics appoints Ramon Polo as head of global regulatory affairs - TipRanks
Aligos Therapeutics appoints Ramón Polo as head of global regulatory - Investing.com
Aligos Therapeutics Appoints Ramón Polo as Senior VP, Head of Global Regulatory Affairs - Quiver Quantitative
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs - The Globe and Mail
Former J&J COVID-19 Vaccine Regulatory Leader Joins Aligos Therapeutics as Global Regulatory Head - Stock Titan
Is Aligos Therapeutics Inc. forming a bottoming baseQuarterly Market Summary & Technical Pattern Recognition Alerts - Newser
Aligos Therapeutics Inc. stock outlook for YEARJuly 2025 Spike Watch & Accurate Intraday Trade Tips - Newser
Sector ETF performance correlation with Aligos Therapeutics Inc.Weekly Risk Summary & Community Verified Trade Signals - Newser
Will Aligos Therapeutics Inc. continue its uptrendWeekly Trend Summary & Fast Gaining Stock Strategy Reports - Newser
Is Aligos Therapeutics Inc. meeting your algorithmic filter criteria2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
What data driven models say about Aligos Therapeutics Inc.’s future2025 Trading Recap & Capital Efficiency Focused Ideas - Newser
Aligos Therapeutics Inc. recovery potential after sell offJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Can volume confirm reversal in Aligos Therapeutics Inc.Bond Market & Safe Capital Growth Tips - Newser
Wall Street Analysts Predict a 983.24% Upside in Aligos Therapeutics (ALGS): Here's What You Should Know - Zacks Investment Research
Will Aligos Therapeutics Inc. stock go up soonJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
Can you recover from losses in Aligos Therapeutics Inc.July 2025 Breakouts & Reliable Price Breakout Alerts - Newser
Aligos Therapeutics Inc. stock momentum explainedJuly 2025 Spike Watch & Safe Entry Point Identification - Newser
Will Aligos Therapeutics Inc. stock recover after recent drop2025 Biggest Moves & AI Driven Stock Reports - Newser
Real time breakdown of Aligos Therapeutics Inc. stock performanceEarnings Risk Report & AI Forecast Swing Trade Picks - Newser
Aligos Therapeutics stock gets Buy rating from H.C. Wainwright on HBV drug potential - Investing.com India
H.C. Wainwright Assumes Coverage of Aligos Therapeutics with Buy Rating - AInvest
Aligos Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks
Aligos Therapeutics receives Buy rating and $50 price target from HC Wainwright & Co. - AInvest
Does Aligos Therapeutics Inc. show high probability of reboundEarnings Overview Report & Low Risk High Win Rate Picks - Newser
Smart tools for monitoring Aligos Therapeutics Inc.’s price actionJuly 2025 Summary & Proven Capital Preservation Tips - Newser
Will Aligos Therapeutics Inc. price bounce be sustainableAnalyst Upgrade & Advanced Swing Trade Entry Plans - Newser
How Efficient Is Aligos Therapeutics Inc. at Controlling Operating CostsJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
Ranking Aligos Therapeutics Inc. among high performing stocks via tools - Newser
How to monitor Aligos Therapeutics Inc. with trend dashboardsWeekly Loss Report & Weekly Watchlist of Top Performers - Newser
Custom watchlist performance reports with Aligos Therapeutics Inc.July 2025 Sector Moves & Community Consensus Trade Alerts - Newser
Volatility clustering patterns for Aligos Therapeutics Inc.Weekly Profit Analysis & Fast Entry Momentum Alerts - Newser
News impact scoring models applied to Aligos Therapeutics Inc.2025 Institutional Moves & Daily Chart Pattern Signals - Newser
Is There Enough Volume to Lift Aligos Therapeutics Inc.Portfolio Update Report & Free Community Supported Trade Ideas - newsyoung.net
What is the dividend yield of Aligos Therapeutics Inc.2025 Trading Recap & Daily Risk Controlled Trade Plans - thegnnews.com
Is Aligos Therapeutics Inc. stock undervalued right nowWeekly Market Summary & AI Driven Price Forecasts - thegnnews.com
Using flow based indicators on Aligos Therapeutics Inc.Trade Volume Report & AI Driven Stock Reports - Newser
Using Bollinger Bands to evaluate Aligos Therapeutics Inc.July 2025 Opening Moves & Real-Time Buy Signal Alerts - Newser
大文字化:
|
ボリューム (24 時間):